Skip to main content
Top
Published in: Osteoporosis International 7/2012

01-07-2012 | Short Communication

Soluble fatty acid synthase relates to bone biomarkers in prepubertal children

Authors: A. Prats-Puig, T. Puig, C. Sitjar, M. Mas-Parareda, P. Grau-Cabrera, P. Soriano-Rodríguez, M. Montesinos-Costa, M. Diaz, F. de Zegher, L. Ibáñez, J. Bassols, A. López-Bermejo

Published in: Osteoporosis International | Issue 7/2012

Login to get access

Abstract

Summary

Circulating soluble fatty acid synthase (FASN, a key enzyme in de novo biosynthesis of fatty acids, expressed in both adipocytes and osteoblasts) is clinically related to a less favorable bone profile in healthy prepubertal children. Soluble FASN may participate in the reciprocal regulation between fat and bone metabolism.

Introduction

Fatty acid synthase (FASN), a key enzyme in de novo biosynthesis of fatty acids, is expressed in adipocytes and osteoblasts. We hypothesized that FASN may participate in the crosstalk between fat and bone. To this aim, we studied the relation between circulating soluble FASN (an extracellular FASN that reflects previously intracellular enzymatic activity) and adipose tissue and bone biomarkers in prepubertal children.

Methods

Circulating soluble FASN, total and high molecular weight (HMW) adiponectin, bone biomarkers [osteocalcin (OC), uncarboxylated osteocalcin (ucOC), C-terminal cross-linked telopeptide of type I collagen (CTX), bone-specific alkaline phosphatase (BSAP)], and a profile of energy metabolism [body fat, insulin resistance and secretion (HOMA), serum lipids] were assessed in 84 asymptomatic prepubertal children (44 girls, 40 boys, age 6.8 ± 0.1 year). Serum 25-OH Vitamin D (Vit D) was additionally measured.

Results

Circulating soluble FASN increased with increasing HMW adiponectin (r = 0.29, p = 0.01) and decreasing serum Vit D (r = −0.21, p < 0.05), and was related to a less favorable bone profile, showing negative associations with bone-derived metabolic parameters [total OC (r = −0.33, p = 0.002) and ucOC (r = −0.37, p < 0.0001)] and a positive association with the CTX-to-BSAP ratio (r = 0.31, p < 0.01). These correlations were not explained by age, gender, body fat, insulin resistance or secretion or serum lipids; however, they were predominant in those subjects with Vit D levels below the population median.

Conclusions

Circulating soluble FASN relates to both adipose tissue and bone biomarkers in prepubertal children, with associations that are dependent on Vit D concentrations. These findings suggest that FASN may participate in the crosstalk between fat and bone metabolism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Confavreux CB (2010) Interactions between bone tissue and energy metabolism. Joint Bone Spine 77:287–289PubMedCrossRef Confavreux CB (2010) Interactions between bone tissue and energy metabolism. Joint Bone Spine 77:287–289PubMedCrossRef
2.
go back to reference Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74PubMedCrossRef Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–74PubMedCrossRef
3.
go back to reference Williams GA, Wang Y, Callon KE, Watson M, Lin JM, Lam JB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603–3610PubMedCrossRef Williams GA, Wang Y, Callon KE, Watson M, Lin JM, Lam JB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603–3610PubMedCrossRef
4.
go back to reference Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469PubMedCrossRef Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456–469PubMedCrossRef
5.
go back to reference Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266–5270PubMedCrossRef Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266–5270PubMedCrossRef
6.
go back to reference Prats-Puig A, Mas-Parareda M, Riera-Perez E, Gonzalez-Forcadell D, Mier C, Mallol-Guisset M, Diaz M, Bassols J, de Zegher F, Ibanez L, Lopez-Bermejo A (2010) Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 33:661–663PubMedCrossRef Prats-Puig A, Mas-Parareda M, Riera-Perez E, Gonzalez-Forcadell D, Mier C, Mallol-Guisset M, Diaz M, Bassols J, de Zegher F, Ibanez L, Lopez-Bermejo A (2010) Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children. Diabetes Care 33:661–663PubMedCrossRef
7.
go back to reference Volpe JJ, Vagelos PR (1976) Mechanisms and regulation of biosynthesis of saturated fatty acids. Physiol Rev 56:339–417PubMed Volpe JJ, Vagelos PR (1976) Mechanisms and regulation of biosynthesis of saturated fatty acids. Physiol Rev 56:339–417PubMed
8.
go back to reference Oliveras-Ferraros C, Vazquez-Martin A, Fernandez-Real JM, Menendez JA (2009) AMPK-sensed cellular energy state regulates the release of extracellular fatty acid synthase. Biochem Biophys Res Commun 378:488–493PubMedCrossRef Oliveras-Ferraros C, Vazquez-Martin A, Fernandez-Real JM, Menendez JA (2009) AMPK-sensed cellular energy state regulates the release of extracellular fatty acid synthase. Biochem Biophys Res Commun 378:488–493PubMedCrossRef
9.
go back to reference Mayas MD, Ortega FJ, Macias-Gonzalez M, Bernal R, Gomez-Huelgas R, Fernandez-Real JM, Tinahones FJ (2010) Inverse relation between FASN expression in human adipose tissue and the insulin resistance level. Nutr Metab (Lond) 7:3CrossRef Mayas MD, Ortega FJ, Macias-Gonzalez M, Bernal R, Gomez-Huelgas R, Fernandez-Real JM, Tinahones FJ (2010) Inverse relation between FASN expression in human adipose tissue and the insulin resistance level. Nutr Metab (Lond) 7:3CrossRef
10.
go back to reference Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Bluher M, Vazquez-Martin A, Vazquez MJ, Ortega F, Dieguez C, Fruhbeck G, Ricart W, Vidal-Puig A (2010) Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes 59:1506–1511PubMedCrossRef Fernandez-Real JM, Menendez JA, Moreno-Navarrete JM, Bluher M, Vazquez-Martin A, Vazquez MJ, Ortega F, Dieguez C, Fruhbeck G, Ricart W, Vidal-Puig A (2010) Extracellular fatty acid synthase: a possible surrogate biomarker of insulin resistance. Diabetes 59:1506–1511PubMedCrossRef
11.
go back to reference Zheng RM, Lin SQ, Liu Y, Huang MT, Gong WY, Wu ZH (2009) Effect of estrogen on gene expression of fatty acid synthase in periosteum. Chin Med J (Engl) 122:1775–1779 Zheng RM, Lin SQ, Liu Y, Huang MT, Gong WY, Wu ZH (2009) Effect of estrogen on gene expression of fatty acid synthase in periosteum. Chin Med J (Engl) 122:1775–1779
12.
go back to reference Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M (2005) Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:1367–1377PubMedCrossRef Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON, Kassem M (2005) Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells 23:1367–1377PubMedCrossRef
13.
go back to reference Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26:97–122PubMed Seibel MJ (2005) Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev 26:97–122PubMed
14.
go back to reference Lund T, Abildgaard N, Andersen TL, Delaisse JM, Plesner T (2010) Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis. Eur J Haematol 84:412–420PubMedCrossRef Lund T, Abildgaard N, Andersen TL, Delaisse JM, Plesner T (2010) Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis. Eur J Haematol 84:412–420PubMedCrossRef
15.
go back to reference Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295PubMedCrossRef Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295PubMedCrossRef
16.
go back to reference Kasai T, Bandow K, Suzuki H, Chiba N, Kakimoto K, Ohnishi T, Kawamoto S, Nagaoka E, Matsuguchi T (2009) Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol 221:740–749PubMedCrossRef Kasai T, Bandow K, Suzuki H, Chiba N, Kakimoto K, Ohnishi T, Kawamoto S, Nagaoka E, Matsuguchi T (2009) Osteoblast differentiation is functionally associated with decreased AMP kinase activity. J Cell Physiol 221:740–749PubMedCrossRef
17.
go back to reference Elbaz A, Wu X, Rivas D, Gimble JM, Duque G (2010) Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 14:982–991PubMedCrossRef Elbaz A, Wu X, Rivas D, Gimble JM, Duque G (2010) Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro. J Cell Mol Med 14:982–991PubMedCrossRef
18.
go back to reference Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF (2000) Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:2274–2284PubMed Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF (2000) Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J Nutr 130:2274–2284PubMed
19.
go back to reference Oh SR, Sul OJ, Kim YY, Kim HJ, Yu R, Suh JH, Choi HS (2009) Saturated fatty acids enhance osteoclast survival. J Lipid Res 51:892–899CrossRef Oh SR, Sul OJ, Kim YY, Kim HJ, Yu R, Suh JH, Choi HS (2009) Saturated fatty acids enhance osteoclast survival. J Lipid Res 51:892–899CrossRef
20.
go back to reference Qiao S, Tuohimaa P (2004) Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells. FEBS Lett 577:451–454PubMedCrossRef Qiao S, Tuohimaa P (2004) Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells. FEBS Lett 577:451–454PubMedCrossRef
Metadata
Title
Soluble fatty acid synthase relates to bone biomarkers in prepubertal children
Authors
A. Prats-Puig
T. Puig
C. Sitjar
M. Mas-Parareda
P. Grau-Cabrera
P. Soriano-Rodríguez
M. Montesinos-Costa
M. Diaz
F. de Zegher
L. Ibáñez
J. Bassols
A. López-Bermejo
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 7/2012
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1759-y

Other articles of this Issue 7/2012

Osteoporosis International 7/2012 Go to the issue